Across the three treatment groups (dulaglutide 1.5 mg, dulaglutide 0.75 mg, and placebo), there were no cases of diabetic ketoacidosis or amputations, and hypotensive episodes/syncope occurred in 0%, 1% and 1%, genital infections in 0%, 0% and 1%, fractures in 1%, 1% and 1%, and gastrointestinal events in 32%, 21% and 17% of patients, respectively [31]
At InjectCo, compounded semaglutide is not offered as a standalone solution
Competing interests: None declared
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are novel drugs approved for diabetes and obesity
Key Ingredients in Inno Shred GLP-1 Berberine Hydrochloride (200mg) : A powerful plant compound that activates the AMPK pathway , promoting GLP-1 production and supporting appetite suppression